You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dexmethylphenidate Hydrochloride

Showing 1 - 25 of 1,786
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Attention Deficit/Hyperactivity Disorder Trial (Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), )

Not yet recruiting
  • Attention Deficit/Hyperactivity Disorder
  • Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
  • placebo
  • (no location specified)
Jan 5, 2023

Attention Deficit/Hyperactivity Disorder Trial (Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH))

Not yet recruiting
  • Attention Deficit/Hyperactivity Disorder
  • Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
  • (no location specified)
Feb 9, 2023

ADHD, ADHD - Combined Type, Attention Deficit Hyper Activity Trial in Maitland, Miami, Las Vegas (CTx-1301 - Dexmethylphenidate

Not yet recruiting
  • ADHD
  • +6 more
  • CTx-1301 - Dexmethylphenidate 6.25mg
  • +6 more
  • Maitland, Florida
  • +2 more
Jun 28, 2023

ADHD, ADHD - Combined Type, ADHD Combined Trial in Las Vegas (CTx-1301 - Dexmethylphenidate 25mg, CTx-1301 - Dexmethylphenidate

Recruiting
  • ADHD
  • +3 more
  • CTx-1301 - Dexmethylphenidate 25mg
  • +3 more
  • Las Vegas, Nevada
    Clinical Research of Southern Nevada, LLC
Jan 23, 2023

Healthy Volunteers in Fed and Fasted State Trial in Overland Park (Dexmethylphenidate)

Completed
  • Healthy Volunteers in Fed and Fasted State
  • Overland Park, Kansas
    Dr. Vince Clinical Research
Oct 18, 2022

ADHD, ADHD, ADHD - Combined Type Trial (CTx-1301 -Dexmethylphenidate 18.75mg, CTx-1301 -Dexmethylphenidate 25mg, CTx-1301

Not yet recruiting
  • ADHD
  • +5 more
  • CTx-1301 -Dexmethylphenidate 18.75mg
  • +3 more
  • (no location specified)
Nov 1, 2022

ADHD Trial in Overland Park (Dexmethylphenidate 5 Mg Oral Capsule, Extended Release, Dexmethylphenidate 6.25 mg Tablet,

Completed
Has Results
  • ADHD
  • Dexmethylphenidate 5 Mg Oral Capsule, Extended Release
  • +3 more
  • Overland Park, Kansas
    Vince & Associates
Mar 15, 2021

Adult ADHD Trial in New York (Serdexmethylphenidate/dexmethylphenidate)

Not yet recruiting
  • Adult Attention Deficit Hyperactivity Disorder
  • New York, New York
    NYU Langone Health
Aug 18, 2023

Auditory Sensitivity in Teens With ADHD

Recruiting
  • Attention Deficit Hyperactivity Disorder
  • +2 more
  • ADHD stimulants, for example, amphetamine, dexmethylphenidate, dextroamphetamine, methylphenidate
  • Wilmington, Delaware
    Nemours Children's Health
Oct 2, 2020

Attention Deficit Disorder With Hyperactivity Trial in Los Angeles (Guanfacine, Methylphenidate (MPH))

Completed
Has Results
  • Attention Deficit Disorder With Hyperactivity
  • Los Angeles, California
    University of California Los Angeles
Jul 9, 2021

Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)

Recruiting
  • Diabetic Peripheral Neuropathic Pain
  • HSK16149 20mg BID
  • Luoyang, Henan, China
    The First Affiliated Hospital of Henan University of Science and
Nov 2, 2023

Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)

Not yet recruiting
  • Laparoscopy
  • Anesthesia, Intravenous
  • Guangzhou, Guangdong, China
  • +11 more
Oct 15, 2023

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin

Not yet recruiting
  • Pain
  • Insomnia
  • Compound ibuprofen polyrelease tablets
  • reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Feb 6, 2023

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Propranolol
  • Propranolol hydrochloride
  • +2 more
  • (no location specified)
Jul 31, 2023

Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • Oral Topotecan Combined With Anlotinib
  • Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023

Associated With Cardiomyopathy and Heart Failure After Cancer

Recruiting
  • Hodgkin Lymphoma in Remission
  • +6 more
  • Assessment of Therapy Complications
  • +3 more
  • Birmingham, Alabama
  • +78 more
Jan 11, 2023

Nalbuphine Allergy, Ablation, Safety Trial in China (Nalbuphine, Morphine)

Recruiting
  • Nalbuphine Allergy
  • +2 more
  • Hefei, Anhui, China
  • +19 more
Dec 28, 2022

Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)

Not yet recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablets
  • Changsha, Hunan, China
    The Third Hospital of Changsha
Nov 9, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in

Active, not recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +8 more
  • 3-Dimensional Conformal Radiation Therapy
  • +8 more
  • Mobile, Alabama
  • +697 more
Nov 16, 2022

Nausea and Vomiting Trial in Xi'an (Palonosetron HCl capsules)

Recruiting
  • Nausea and Vomiting
  • Palonosetron hydrochloride capsules
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital, the Air Force Medical University
Jan 18, 2023

Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in United States (Fluorouracil, Gemcitabine Hydrochloride,

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Carcinoma
  • Birmingham, Alabama
  • +806 more
Oct 18, 2022

Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)

Recruiting
  • Lymphoma, Solid Tumors
  • Mitoxantrone Hydrochloride Liposome
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2022

Oxycodone Sustained-release Tablets for Moderate to Severe

Recruiting
  • Cancer Pain
  • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 24, 2023